Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-074855
Filing Date
2024-06-18
Accepted
2024-06-18 16:10:03
Documents
2
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2189
2 EX-24.1 fulc-ex24_1.htm EX-24.1 11220
  Complete submission text file 0000950170-24-074855.txt   14777
Mailing Address 196 BROADWAY CAMBRIDGE MA 02139
Business Address
Hill Colin (Reporting) CIK: 0001673192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38978 | Film No.: 241051832

Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Issuer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)